Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · May 27, 2023

ctDNA Analysis of KIT/PDGFRA-Mutated Advanced GIST Treated With Avapritinib or Regorafenib

Annals of Oncology


Additional Info

Annals of Oncology
Circulating tumor DNA analysis of the phase III VOYAGER trial: KIT mutational landscape and outcomes in patients with advanced gastrointestinal stromal tumor treated with avapritinib or regorafenib
Ann. Oncol 2023 Apr 25;[EPub Ahead of Print], C Serrano, S Bauer, D Gómez-Peregrina, YK Kang, RL Jones, P Rutkowski, O Mir, MC Heinrich, WD Tap, K Newberry, A Grassian, H Shi, S Bialick, P Schöffski, MA Pantaleo, M von Mehren, JC Trent, S George

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading